Assessing Carter's (CRI) Valuation After Recent Share Price Momentum

What Carter's Stock Performance Tells You Right Now

Carter's (CRI) has traded around $35.91 recently, with returns of about 0.9% over the past day, 3.1% over the past week, and 5.9% over the past month catching investor attention.

See our latest analysis for Carter's.

Recent share price returns of around 8% year to date contrast with a flat 1 year total shareholder return and weaker 3 and 5 year total shareholder returns. This suggests short term momentum against a softer long term record.

If Carter's has you reassessing your portfolio, this is a good moment to broaden your search and uncover 20 top founder-led companies

With Carter's trading close to a modest discount to analyst targets and only a small intrinsic premium on some models, the key question is whether you are seeing hidden value here or a price that already reflects future growth.

Most Popular Narrative: 3% Undervalued

The widely followed narrative puts Carter's fair value at $37.00 per share, a touch above the recent $35.91 price, which frames the stock as slightly discounted.

Carter's brand maturity and limited international penetration constrain organic top-line growth. International expansion remains modest despite stronger growth in markets like Brazil, suggesting forward earnings growth will remain capped. Heightened focus on cost inflation, tariffs, and sustainability investing (including supply chain re-engineering and higher material costs) is likely to weigh on gross margins and operating income in the medium term, limiting net earnings expansion even if some price increases are realized.

Read the complete narrative.

Want to see how modest growth expectations still support that price tag? The narrative leans heavily on steady revenue, firmer margins, and a valuation multiple that needs careful scrutiny.

Result: Fair Value of $37 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, there are also upside risks, including growth from international markets like Mexico, Canada, and Brazil, as well as traction from new premium and sustainable baby brands.

Find out about the key risks to this Carter's narrative.

Another Way To Look At Carter's Value

The valuation narrative points to Carter's as slightly undervalued, but the current P/E of 14.8x sits very close to its fair ratio of 14.4x, and well below the US Luxury peer average of 18.7x. That mix suggests limited margin for error. Is this a cushion or a value trap in the making?

To pressure test your view against what the P/E gaps are signalling, take a look at the See what the numbers say about this price — find out in our valuation breakdown.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Carter's for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 58 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Mixed signals on value and future potential can be confusing, so move quickly from reading to checking the data yourself and weigh both sides of the story with 2 key rewards and 2 important warning signs

Looking for more investment ideas?

If Carter's has sharpened your focus, do not stop here; widen your watchlist now or you risk missing opportunities sitting in plain sight.

• Target reliable income potential by reviewing companies in the 13 dividend fortresses that put cash returns to shareholders front and center.
• Hunt for quality at a discount with the 58 high quality undervalued stocks and see which businesses combine solid fundamentals with appealing prices.
• Prioritize capital preservation by scanning the 68 resilient stocks with low risk scores to find companies with resilient profiles that may help smooth portfolio volatility.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com